HSD88 Current Epcoritamab Plus Rituximab and Lenalidomide (R2) Perceptions for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL)

Saved in:
Bibliographic Details
Published in:Value in health 2024-12, Vol.27 (12), p.S342-S342
Main Authors: Levine, E, Gentile, D, Swain, R, Bone, R.N., Jennings-Zhang, L., Jeune-Smith, Y., Feinberg, B
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2024.10.1771